LYSINE DEMETHYLASE INHIBITORS FOR THROMBOSIS AND CARDIOVASCULAR DISEASES
1 Assignment
0 Petitions
Accused Products
Abstract
The invention relates to methods and compositions for the treatment or prevention of thrombosis, thrombus formation, a thrombotic event or complication, or a cardiovascular disease or event. In particular, the invention relates to an LSD inhibitor such as a 2-cyclylcyclopropan-1-amine derivative, a phenelzine derivative and a propargylamine derivative, for use in treating or preventing thrombosis, thrombus formation, a thrombotic event or complication, or a cardiovascular disease or event.
-
Citations
61 Claims
-
1-4. -4. (canceled)
- 5. A method of treating or preventing thrombosis, thrombus formation, a thrombotic event or complication or a cardiovascular disease or event, comprising administering to an individual a therapeutically effective amount of a LSD1 inhibitor.
-
6. A method of treating or preventing a symptom of thrombosis, thrombus formation, a thrombotic event or complication or a cardiovascular disease or event, comprising administering to an individual a therapeutically effective amount of a LSD1 inhibitor.
-
8-10. -10. (canceled)
-
11. A method of reducing or preventing the risk of thrombosis, thrombus formation, a thrombotic event or complication or a cardiovascular disease or event, wherein said thrombosis, thrombus formation, thrombotic event or complication, or cardiovascular disease or event is associated with or caused by inflammatory diseases, infections, acute blood loss, haemolytic anaemias, percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG) and similar medical procedures, tissue damage from accident, microsurgery, angioplasty or trauma, medications, cancer chemotherapy, cancer, polycythemia vera or myeloproliferative disorders, diabetes, celiac disease, renal disorders or splenectomy, comprising administering to an individual a therapeutically effective amount of a LSD1 inhibitor.
-
14. (canceled)
-
18-19. -19. (canceled)
-
23. (canceled)
-
25-33. -33. (canceled)
-
35-36. -36. (canceled)
-
39-41. -41. (canceled)
-
43-49. -49. (canceled)
-
52-59. -59. (canceled)
-
61-72. -72. (canceled)
Specification